Novo Nordisk A/S

NVO

$46.72

Name : Novo Nordisk A/S

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $204,687,343,616.00

EPSttm : 4.08

Novo Nordisk A/S

$46.72

0.71%

$0.33

NVO — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.88

Margin Of Safety %

Put/Call OI Ratio

0.66

EPS Next Q Diff

-0.27

EPS Last/This Y

0.01

EPS This/Next Y

-0.21

Price

46.73

Target Price

49.16

Analyst Recom

2.43

Performance Q

-0.74

Upside

13.8%

Beta

0.76

Ticker: NVO

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-15	NVO	50.55	0.69	0.25	1378179
2026-07-16	NVO	51.47	0.68	0.47	1399582
2026-07-17	NVO	50.31	0.69	0.94	1420850
2026-07-20	NVO	49.64	0.62	0.38	1252523
2026-07-21	NVO	49.35	0.62	0.66	1274526
2026-07-22	NVO	48.13	0.62	0.55	1286624
2026-07-23	NVO	48.19	0.62	0.61	1298591
2026-07-24	NVO	48.77	0.62	0.65	1307041
2026-07-27	NVO	49.69	0.63	0.53	1286743
2026-07-28	NVO	50.79	0.63	0.40	1300960
2026-07-29	NVO	51.57	0.63	0.76	1315927
2026-07-30	NVO	51.58	0.63	0.72	1338202
2026-07-31	NVO	47.11	0.64	0.54	1369868
2026-08-03	NVO	47.09	0.65	0.53	1346564
2026-08-04	NVO	44.32	0.65	0.73	1387002
2026-08-05	NVO	44.65	0.65	0.46	1477644
2026-08-07	NVO	47.26	0.65	0.36	1507841
2026-08-13	NVO	46.72	0.66	0.42	1482902
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-15	NVO	50.55	-13.1	-4192.4	21.61
2026-07-16	NVO	51.46	-13.1	-4477.9	21.61
2026-07-17	NVO	50.31	-15.7	-5033.2	21.86
2026-07-20	NVO	49.65	-15.7	-4954.6	21.86
2026-07-21	NVO	49.37	-15.7	-5009.4	21.86
2026-07-22	NVO	48.19	-15.7	-4989.6	21.86
2026-07-23	NVO	48.19	-15.7	-4748.9	21.86
2026-07-24	NVO	48.78	-16.4	-4563.6	21.77
2026-07-27	NVO	49.67	-16.4	-4252.3	21.77
2026-07-28	NVO	50.96	-16.4	-4110.5	21.77
2026-07-29	NVO	51.59	-16.4	-4982.6	21.77
2026-07-30	NVO	51.59	-16.4	-5122.0	21.77
2026-07-31	NVO	47.12	-16.4	-6299.5	21.77
2026-08-03	NVO	47.09	-16.4	-5001.2	3.35
2026-08-04	NVO	47.09	-16.4	-5001.2	3.35
2026-08-05	NVO	44.49	-16.4	-4289.9	3.40
2026-08-06	NVO	45.97	-16.4	-3771.8	3.40
2026-08-07	NVO	47.24	4.6	-1075.1	19.43
2026-08-13	NVO	46.73	14.2	-3350.5	3.57
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-15	NVO	0	-2.79	0.83
2026-07-16	NVO	0	-2.79	0.83
2026-07-17	NVO	0	-2.79	0.83
2026-07-20	NVO	0	-2.77	0.83
2026-07-21	NVO	0	-2.77	0.83
2026-07-22	NVO	0	-2.77	0.83
2026-07-23	NVO	0	-2.77	0.83
2026-07-24	NVO	0	-2.77	0.83
2026-07-27	NVO	0	-3.46	0.93
2026-07-28	NVO	0	-3.46	0.93
2026-07-29	NVO	0	-3.46	0.93
2026-07-30	NVO	0	-3.46	0.93
2026-07-31	NVO	0	-3.46	0.93
2026-08-03	NVO	0	-3.35	0.93
2026-08-04	NVO	0	-3.35	0.93
2026-08-05	NVO	0	-3.35	0.93
2026-08-06	NVO	0	-3.35	0.93
2026-08-13	NVO	0	-3.53	0.88
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.96

Avg. EPS Est. Current Quarter

0.79

Avg. EPS Est. Next Quarter

0.69

Insider Transactions

Institutional Transactions

-3.53

Beta

0.76

Average Sales Estimate Current Quarter

11268

Average Sales Estimate Next Quarter

11431

Fair Value

50.13

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

68.5

Max Drawdown 5-Year %

-74.7

Target Price

49.16

P/E

11.42

Forward P/E

13.99

PEG

P/S

3.04

P/B

6.1

P/Free Cash Flow

13.26

EPS

4.09

Average EPS Est. Cur. Y

3.57

EPS Next Y. (Est.)

3.36

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

35.36

Relative Volume

0.82

Return on Equity vs Sector %

26.1

Return on Equity vs Industry %

16.5

EPS 1 7Days Diff

0.2

EPS 1 30Days Diff

0.23

EBIT Estimation

-3350.5

◆ NVO Healthcare

$46.73

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

19/25

Volume

4/15

Valuation

14/20

TP/AR

1/10

Options

7/10

RSI

46.1

Range 1M

31.4%

Sup Dist

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

7/30

Estimates

5/20

Inst/Vol

0/15

Options

6/10

EPS Yr

-7.1%

EPS NY

-1.1%

52W%

38.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +-0% upside

Quality

28/30

Valuation

7/30

Growth

6/25

Stability

3/10

LT Trend

2/5

Upside

-0%

Quality

MoS

NVO — P/E HistoricalDrug Manufacturers - General

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 66700

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

NVO

Latest News

—

Caricamento notizie per NVO…

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y